Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland

被引:2
|
作者
Prami, Tuire [1 ]
Polkki, Mari [1 ]
Ruotsalainen, Jarno [1 ]
Nordbeck, Elin Banke [2 ]
Meyner, Susanna [2 ]
Kaski, Ari [3 ]
机构
[1] Oriola, Espoo, Finland
[2] Camurus AB, Lund, Sweden
[3] Kuopio Addict Med Ctr, Kuopio, Finland
关键词
buprenorphine; high-risk opioid use; intravenous opioid use; opioid agonist treatment; opioid dependence;
D O I
10.1177/14550725231204723
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: To characterise and understand the untreated high-risk opioid user population in Finland, and to determine the reasons why these people do not enter treatment. Methods: The study setting was a half-year cross-sectional survey in Finland during 2021-2022. An electronic questionnaire with 24 structured questions was concluded in 16 needle exchange units. Participants were opioid-dependent people without opioid agonist treatment (OAT), and they answered the survey voluntarily and anonymously. Results: Of the 167 respondents, 62% were men, 53% were aged <= 34 years, 66% had used opioids for >6 years, and 78% used drugs intravenously (IV) daily. The most used opioid (95%) was buprenorphine. Most respondents used opioids as self-medication for withdrawal symptoms (75%), or to treat psychological symptoms (59%) or pain (43%). Of them, 70% also used other substances for recreational purposes. The most common named reasons to stay outside OAT were as follows: seeking treatment is too difficult (37%); treatment is too binding (36%); and fear of actions from authorities (23%). Conclusions: For opioid-dependent respondents who would be eligible for OAT in Finland, treatment awareness is limited. These high-risk opioid users also think that the treatment would be too binding. In conclusion, there is a need for increase in general information about, accessibility to, acceptance for and individualisation of OAT.
引用
收藏
页码:200 / 211
页数:12
相关论文
共 50 条
  • [1] Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users
    Schiavon, Samantha
    Hodgin, Kathleen
    Sellers, Aaron
    Word, Margaret
    Galbraith, James W.
    Dantzler, John
    Cropsey, Karen L.
    [J]. ADDICTIVE BEHAVIORS, 2018, 86 : 51 - 55
  • [2] Sleep problems reported by patients entering opioid agonist treatment
    Burke, Christopher K.
    Peirce, Jessica M.
    Kidorf, Michael S.
    Neubauer, David
    Punjabi, Naresh M.
    Stoller, Kenneth B.
    Hursh, Steve
    Brooner, Robert K.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2008, 35 (03) : 328 - 333
  • [3] Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis
    Hinami, Keiki
    Ray, Michael J.
    Doshi, Kruti
    Torres, Maria
    Aks, Steven
    Shannon, John J.
    Trick, William E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (11) : 2443 - 2450
  • [4] Hospital admission medication reconciliation in high-risk prescription opioid users
    Rodriguez-Monguio, Rosa
    Lun, Zhixin
    Kehr, Kendall
    Agustin, Janelle P.
    Agustin-Nordmeier, Kaycee San
    Huynh, Christine
    Reisner, Lori
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (08): : 3379 - 3385
  • [5] Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis
    Keiki Hinami
    Michael J. Ray
    Kruti Doshi
    Maria Torres
    Steven Aks
    John J. Shannon
    William E. Trick
    [J]. Journal of General Internal Medicine, 2019, 34 : 2443 - 2450
  • [6] Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
    Bhat, Fazle R.
    Rather, Yasir H.
    Rasool, Ubaid
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2022, 13 (02) : 176 - 180
  • [7] High-risk opioid utilization and mortality among hemodialysis patients
    Daubresse, Matthew
    Alexander, G. Caleb
    Crews, Deidra C.
    Segev, Dorry L.
    McAdams-DeMarco, Mara A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 213 - 214
  • [8] Opioid safety among high-risk cancer survivors.
    Salz, Talya
    Mishra, Akriti A.
    Gennarelli, Renee L.
    Lipitz-Snyderman, Allison
    Boudreau, Denise
    Moryl, Natalie
    Tringale, Kathryn Ries
    Korenstein, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence
    Bharat, Chrianna
    Gisev, Natasa
    Barbieri, Sebastiano
    Dobbins, Timothy
    Larney, Sarah
    Buizen, Luke
    Degenhardt, Louisa
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [10] Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt
    Min, Jeong Eun
    Guerra-Alejos, Brenda Carolina
    Yan, Ruyu
    Palis, Heather
    Barker, Brittany
    Urbanoski, Karen
    Pauly, Bernie
    Slaunwhite, Amanda
    Bach, Paxton
    Ranger, Corey
    Heaslip, Ashley
    Nosyk, Bohdan
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)